{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:18:28Z","timestamp":1783423108784,"version":"3.54.6"},"reference-count":107,"publisher":"IMR Press","issue":"6","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Early palliative care (EPC) has been shown to improve the quality of life of patients with advanced malignancies, although its role within the context of newer cancer therapeutics requires further research. Despite endorsement by national and international guidelines, EPC remains an aspirational ideal rather than a routine practice. Implementation is hindered by limited resources, clinician hesitancy to refer and patient- and family-related factors. To translate evidence into practice, future initiatives must focus on service innovations that operate within existing constraints. Stepped models, patient-reported outcome measures, telehealth, and machine learning represent promising approaches to achieving this goal. This review summarises the evidence surrounding EPC, outlines key barriers to its delivery and examines emerging strategies to improve its integration into oncological care.<\/jats:p>","DOI":"10.31083\/bjhm55141","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:55:28Z","timestamp":1783421728000},"source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of Early Palliative Care in Advanced Malignancy: Evidence, Challenges and Paths Ahead"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8783-7397","authenticated-orcid":true,"given":"Freya","family":"Daws","sequence":"first","affiliation":[{"name":"Medical Division, North Bristol NHS Trust, BS10 5NB Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Wiggins","sequence":"additional","affiliation":[{"name":"End of Life and Palliative Care Department, Great Western Hospitals NHS Foundation Trust, SN3 6BB Swindon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Franciosi V, Maglietta G, Degli Esposti C, Caruso G, Cavanna L, Bert\u00e8 R, et al. Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial. Annals of Palliative Medicine. 2019; 8: 381\u2013389.","DOI":"10.21037\/apm.2019.02.07"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. The New England Journal of Medicine. 2010; 363: 733\u2013742.","DOI":"10.1056\/NEJMoa1000678"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R, et al. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. The Lancet. Oncology. 2018; 19: 394\u2013404.","DOI":"10.1016\/S1470-2045(18)30060-3"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014; 383: 1721\u20131730.","DOI":"10.1016\/S0140-6736(13)62416-2"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Johnson MJ, Rutterford L, Sunny A, Pask S, de Wolf-Linder S, Murtagh FEM, et al. Benefits of specialist palliative care by identifying active ingredients of service composition, structure, and delivery model: A systematic review with meta-analysis and meta-regression. PLoS Medicine. 2024; 21: e1004436.","DOI":"10.1371\/journal.pmed.1004436"},{"key":"ref6","unstructured":"Anderson V, Beckett P, Doffman S, Gouveia R, Hugh M, Toy E. Lung Cancer best practice guidance. A practical guide to support implementation of the GIRFT Lung Cancer National Report recommendations. 2022. Available at: https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2022\/11\/Lung-Cancer-best-practice-guidance-November-2022.pdf (Accessed: 30 September 2025)."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 2024; 42: 2336\u20132357.","DOI":"10.1200\/JCO.24.00542"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Jordan RI, Allsop MJ, ElMokhallalati Y, Jackson CE, Edwards HL, Chapman EJ, et al. Duration of palliative care before death in international routine practice: a systematic review and meta-analysis. BMC Medicine. 2020; 18: 368.","DOI":"10.1186\/s12916-020-01829-x"},{"key":"ref9","unstructured":"NICE. Palliative care - general issues: Management approach. 2025. Available at: https:\/\/cks.nice.org.uk\/topics\/palliative-care-general-issues\/management\/management-approach\/ (Accessed: 30 September 2025)."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Quinn KL, Shurrab M, Gitau K, Kavalieratos D, Isenberg SR, Stall NM, et al. Association of Receipt of Palliative Care Interventions With Health Care Use, Quality of Life, and Symptom Burden Among Adults With Chronic Noncancer Illness: A Systematic Review and Meta-analysis. JAMA. 2020; 324: 1439\u20131450.","DOI":"10.1001\/jama.2020.14205"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Fordjour GA, Chow AYM, Hui VKY, Chan CLW. Comparative analysis of symptom burdens and influential factors among diverse terminally-ill patients. Annals of Palliative Medicine. 2024; 13: 513\u2013530.","DOI":"10.21037\/apm-23-565"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lau C, Meaney C, Morgan M, Cook R, Zimmermann C, Wentlandt K. Disparities in access to palliative care facilities for patients with and without cancer: A retrospective review. Palliative Medicine. 2021; 35: 1191\u20131201.","DOI":"10.1177\/02692163211007387"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Hui D, Meng YC, Bruera S, Geng Y, Hutchins R, Mori M, et al. Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review. The Oncologist. 2016; 21: 895\u2013901.","DOI":"10.1634\/theoncologist.2016-0006"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Tattersall MH, Martin A, Devine R, Ryan J, Jansen J, Hastings L, et al. Early contact with palliative care services: a randomized trial in patients with newly detected incurable metastatic cancer. Journal of Palliative Care & Medicine. 2014; 4: 1000170.","DOI":"10.4172\/2165-7386.1000170"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Scarpi E, Dall\u2019Agata M, Zagonel V, Gamucci T, Bert\u00e8 R, Sansoni E, et al. Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes. Supportive Care in Cancer. 2019; 27: 2425\u20132434.","DOI":"10.1007\/s00520-018-4517-2"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Eychm\u00fcller S, Zwahlen S, Fliedner MC, J\u00fcni P, Aebersold DM, Aujesky D, et al. Single early palliative care intervention added to usual oncology care for patients with advanced cancer: A randomized controlled trial (SENS Trial). Palliative Medicine. 2021; 35: 1108\u20131117.","DOI":"10.1177\/02692163211005340"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial. Journal of Clinical Oncology. 2017; 35: 834\u2013841.","DOI":"10.1200\/JCO.2016.70.5046"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Klinger CA, Howell D, Zakus D, Deber RB. Barriers and facilitators to care for the terminally ill: a cross-country case comparison study of Canada, England, Germany, and the United States. Palliative Medicine. 2014; 28: 111\u2013120.","DOI":"10.1177\/0269216313493342"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009; 302: 741\u2013749.","DOI":"10.1001\/jama.2009.1198"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. Journal of Pain and Symptom Management. 2007; 33: 238\u2013246.","DOI":"10.1016\/j.jpainsymman.2006.10.010"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. Journal of Clinical Oncology. 2015; 33: 1438\u20131445.","DOI":"10.1200\/JCO.2014.58.6362"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Kang E, Kang JH, Koh SJ, Kim YJ, Seo S, Kim JH, et al. Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Network Open. 2024; 7: e2426304.","DOI":"10.1001\/jamanetworkopen.2024.26304"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sullivan DR, Chan B, Lapidus JA, Ganzini L, Hansen L, Carney PA, et al. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration. JAMA Oncology. 2019; 5: 1702\u20131709.","DOI":"10.1001\/jamaoncol.2019.3105"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Adenis A, Da Silva A, Ben Abdelghani M, Bourgeois V, Bogart E, Turpin A, et al. Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial. eClinicalMedicine. 2024; 74: 102470.","DOI":"10.1016\/j.eclinm.2024.102470"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Maltoni M, Scarpi E, Dall\u2019Agata M, Zagonel V, Bert\u00e8 R, Ferrari D, et al. Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. European Journal of Cancer. 2016; 65: 61\u201368.","DOI":"10.1016\/j.ejca.2016.06.007"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Gautama MSN, Damayanti A, Khusnia AF. Impact of Early Palliative Care to Improve Quality of Life of Advanced Cancer Patients: A Meta-Analysis of Randomised Controlled Trials. Indian Journal of Palliative Care. 2023; 29: 28\u201335.","DOI":"10.25259\/IJPC_153_2022"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Haun MW, Estel S, R\u00fccker G, Friederich HC, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. The Cochrane Database of Systematic Reviews. 2017; 6: CD011129.","DOI":"10.1002\/14651858.CD011129.pub2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Huo B, Song Y, Chang L, Tan B. Effects of early palliative care on patients with incurable cancer: A meta-analysis and systematic review. European Journal of Cancer Care. 2022; 31: e13620.","DOI":"10.1111\/ecc.13620"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Shih HH, Chang HJ, Huang TW. Effects of Early Palliative Care in Advanced Cancer Patients: A Meta-Analysis. The American Journal of Hospice & Palliative Care. 2022; 39: 1350\u20131357.","DOI":"10.1177\/10499091221075570"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. The Lancet. Oncology. 2016; 17: e552\u2013e559.","DOI":"10.1016\/S1470-2045(16)30577-0"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 2017; 35: 96\u2013112.","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Hui D, Heung Y, Bruera E. Timely Palliative Care: Personalizing the Process of Referral. Cancers. 2022; 14: 1047.","DOI":"10.3390\/cancers14041047"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Araghi M, Mannani R, Heidarnejad Maleki A, Hamidi A, Rostami S, Safa SH, et al. Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell International. 2023; 23: 162.","DOI":"10.1186\/s12935-023-02990-y"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Canavan ME, Wang X, Ascha MS, Miksad RA, Calip GS, Gross CP, et al. Systemic Anticancer Therapy at the End of Life-Changes in Usage Pattern in the Immunotherapy Era. JAMA Oncology. 2022; 8: 1847\u20131849.","DOI":"10.1001\/jamaoncol.2022.4666"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Lloyd MR, Wander SA, Hamilton E, Razavi P, Bardia A. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Therapeutic Advances in Medical Oncology. 2022; 14: 17588359221113694.","DOI":"10.1177\/17588359221113694"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Santini D, Zeppola T, Russano M, Citarella F, Anesi C, Buti S, et al. PD-1\/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. Journal of Translational Medicine. 2021; 19: 270.","DOI":"10.1186\/s12967-021-02937-9"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Fitzsimmons TS, Singh N, Walker TDJ, Newton C, Evans DGR, Crosbie EJ, et al. Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis. Frontiers in Medicine. 2023; 10: 1192762.","DOI":"10.3389\/fmed.2023.1192762"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Zhou Y, Chen C, Zhang X, Fu S, Xue C, Ma Y, et al. Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis. Journal for Immunotherapy of Cancer. 2018; 6: 155.","DOI":"10.1186\/s40425-018-0477-9"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Geijteman ECT, Kuip EJM, Oskam J, Lees D, Bruera E. Illness trajectories of incurable solid cancers. BMJ (Clinical Research Ed.). 2024; 384: e076625.","DOI":"10.1136\/bmj-2023-076625"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Rivera-Concepcion J, Uprety D, Adjei AA. Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer. Cancer Research and Treatment. 2022; 54: 315\u2013329.","DOI":"10.4143\/crt.2022.078"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Temel JS, Petrillo LA, Greer JA. Patient-Centered Palliative Care for Patients With Advanced Lung Cancer. Journal of Clinical Oncology. 2022; 40: 626\u2013634.","DOI":"10.1200\/JCO.21.01710"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Petrillo LA, El-Jawahri A, Nipp RD, Lichtenstein MRL, Durbin SM, Reynolds KL, et al. Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 2020; 126: 2288\u20132295.","DOI":"10.1002\/cncr.32782"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Petrillo LA, El-Jawahri A, Gallagher ER, Jackson VA, Temel JS, Greer JA. Patient-Reported and End-of-Life Outcomes Among Adults With Lung Cancer Receiving Targeted Therapy in a Clinical Trial of Early Integrated Palliative Care: A Secondary Analysis. Journal of Pain and Symptom Management. 2021; 62: e65\u2013e74.","DOI":"10.1016\/j.jpainsymman.2021.02.010"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Lai-Kwon J, Heynemann S, Flore J, Dhillon H, Duffy M, Burke J, et al. Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy. Journal of Cancer Survivorship. 2021; 15: 392\u2013397.","DOI":"10.1007\/s11764-021-01024-8"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Petrillo LA, Traeger LN, Sommer RK, Zhou AZ, Temel JS, Greer JA. Experience and supportive care needs of metastatic lung cancer survivors living with uncertainty: a brief qualitative report. Journal of Cancer Survivorship: Research and Practice. 2021; 15: 386\u2013391.","DOI":"10.1007\/s11764-021-01016-8"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Annals of Oncology. 2020; 31: 96\u2013102.","DOI":"10.1016\/j.annonc.2019.10.006"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Basak D, Arrighi S, Darwiche Y, Deb S. Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life. 2021; 12: 48.","DOI":"10.3390\/life12010048"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Johnson DB, Nebhan CA, Moslehi JJ, Balko JM. Immune-checkpoint inhibitors: long-term implications of toxicity. Nature Reviews. Clinical Oncology. 2022; 19: 254\u2013267.","DOI":"10.1038\/s41571-022-00600-w"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Majem M, Molina Mata K, Mayor Ibarguren A, Zafra Poves M, Requena C, Aparisi Aparisi FDA, et al. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology. Clinical & Translational Oncology. 2026.  (online ahead of print)","DOI":"10.1007\/s12094-025-04209-0"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduction and Targeted Therapy. 2023; 8: 262.","DOI":"10.1038\/s41392-023-01469-6"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Da Cunha T, Wu GY, Vaziri H. Immunotherapy-induced Hepatotoxicity: A Review. Journal of Clinical and Translational Hepatology. 2022; 10: 1194\u20131204.","DOI":"10.14218\/JCTH.2022.00105"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Roberts K, Culleton V, Lwin Z, O\u2019Byrne K, Hughes BG. Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities. Asia-Pacific Journal of Clinical Oncology. 2017; 13: 277\u2013288.","DOI":"10.1111\/ajco.12698"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Strunk A, Batzler YN, Ziemer M, Neukirchen M, Schwartz J, Sachse M, et al. Raising awareness of immune-related side effects in oncological patients under palliative care: a report of two cases. Annals of Palliative Medicine. 2023; 12: 826\u2013833.","DOI":"10.21037\/apm-22-1077"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Cooksley T, Gupta A, Al-Sayed T, Lorigan P. Emergency presentations in patients treated with immune checkpoint inhibitors. European Journal of Cancer. 2020; 130: 193\u2013197.","DOI":"10.1016\/j.ejca.2020.02.025"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Ruben CL, Jolley DM, Owen DH, Bischof JJ. Immune-Related Adverse Events in Patients on Immunotherapy Presenting to the Emergency Department: A Retrospective Cohort Study. The Journal of Emergency Medicine. 2024; 66: e53.","DOI":"10.1016\/j.jemermed.2023.06.030"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Daniels GA, Guerrera AD, Katz D, Viets-Upchurch J. Challenge of immune-mediated adverse reactions in the emergency department. Emergency Medicine Journal. 2019; 36: 369\u2013377.","DOI":"10.1136\/emermed-2018-208206"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Scholz B, Goncharov L, Emmerich N, Lu VN, Chapman M, Clark SJ, et al. Clinicians\u2019 accounts of communication with patients in end-of-life care contexts: A systematic review. Patient Education and Counseling. 2020; 103: 1913\u20131921.","DOI":"10.1016\/j.pec.2020.06.033"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Lupu D, Quigley L, Mehfoud N, Salsberg ES. The Growing Demand for Hospice and Palliative Medicine Physicians: Will the Supply Keep Up? Journal of Pain and Symptom Management. 2018; 55: 1216\u20131223.","DOI":"10.1016\/j.jpainsymman.2018.01.011"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Wang K, Ariello K, Choi M, Turner A, Wan BA, Yee C, et al. Sexual healthcare for cancer patients receiving palliative care: a narrative review. Annals of Palliative Medicine. 2018; 7: 256\u2013264.","DOI":"10.21037\/apm.2017.10.05"},{"key":"ref60","unstructured":"MASCC. What is Supportive Care? 2025. Available at: https:\/\/mascc.org\/what-is-supportive-care\/ (Accessed: 30 September 2025)."},{"key":"ref61","unstructured":"United Kingdom Association of Supportive Care in Cancer (UKASCC). UKASCC - About. 2025. Available at: https:\/\/ukascc.org\/about\/ (Accessed: 30 September 2025)."},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Boltezar L, Novakovic BJ, Moltara ME. Trends in specialized palliative care referrals at an oncology center from 2007 to 2019. BMC Palliative Care. 2021; 20: 135.","DOI":"10.1186\/s12904-021-00828-w"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Hausner D, Tricou C, Mathews J, Wadhwa D, Pope A, Swami N, et al. Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care. The Oncologist. 2021; 26: 332\u2013340.","DOI":"10.1002\/onco.13625"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Wong A, Vidal M, Prado B, Hui D, Epner M, Balankari VR, et al. Patients\u2019 Perspective of Timeliness and Usefulness of an Outpatient Supportive Care Referral at a Comprehensive Cancer Center. Journal of Pain and Symptom Management. 2019; 58: 275\u2013281.","DOI":"10.1016\/j.jpainsymman.2019.04.027"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Adamidis F, Baumgartner NS, Kitta A, Kum L, Ecker F, B\u00e4r J, et al. Timely integration of palliative care. the reality check. a retrospective analysis. Supportive Care in Cancer. 2024; 32: 518.","DOI":"10.1007\/s00520-024-08721-x"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Feld E, Singhi EK, Phillips S, Huang LC, Shyr Y, Horn L. Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices. Clinical Lung Cancer. 2019; 20: e291\u2013e298.","DOI":"10.1016\/j.cllc.2019.02.002"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Martin A, Carton M, Thery L, Burnod A, Daniel C, Du Rusquec P, et al. Palliative care integration and end-of-life care intensity for patients with NSCLC. Lung Cancer. 2024; 192: 107800.","DOI":"10.1016\/j.lungcan.2024.107800"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Tagami K, Masukawa K, Inoue A, Morita T, Hiratsuka Y, Sato M, et al. Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units. Supportive Care in Cancer. 2022; 30: 931\u2013940.","DOI":"10.1007\/s00520-021-06493-2"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"de Oliveira Valentino TC, Paiva BSR, de Oliveira MA, Hui D, Paiva CE. Factors associated with palliative care referral among patients with advanced cancers: a retrospective analysis of a large Brazilian cohort. Supportive Care in Cancer. 2018; 26: 1933\u20131941.","DOI":"10.1007\/s00520-017-4031-y"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"J\u00f8hnk C, Laigaard HH, Pedersen AK, Bauer EH, Brandt F, Bollig G, et al. Time to End-of-Life of Patients Starting Specialised Palliative Care in Denmark: A Descriptive Register-Based Cohort Study. International Journal of Environmental Research and Public Health. 2022; 19: 13017.","DOI":"10.3390\/ijerph192013017"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"M\u00fcller S, Fink M, Hense J, Comino MRS, Schuler M, Teufel M, et al. Palliative care outpatients in a German comprehensive cancer center-identifying indicators for early and late referral. BMC Palliative Care. 2022; 21: 221.","DOI":"10.1186\/s12904-022-01114-z"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Riaz F, Gan G, Li F, Davidoff AJ, Adelson KB, Presley CJ, et al. Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life. JCO Oncology Practice. 2020; 16: e1355\u2013e1370.","DOI":"10.1200\/OP.20.00010"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Sorensen A, Wentlandt K, Le LW, Swami N, Hannon B, Rodin G, et al. Practices and opinions of specialized palliative care physicians regarding early palliative care in oncology. Supportive Care in Cancer. 2020; 28: 877\u2013885.","DOI":"10.1007\/s00520-019-04876-0"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Salins N, Ghoshal A, Hughes S, Preston N. How views of oncologists and haematologists impacts palliative care referral: a systematic review. BMC Palliative Care. 2020; 19: 175.","DOI":"10.1186\/s12904-020-00671-5"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. Canadian Medical Association Journal. 2016; 188: E217\u2013E227.","DOI":"10.1503\/cmaj.151171"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Bandieri E, Borelli E, Gilioli F, Bigi S, Mucciarini C, Ferrari U, et al. Stigma of Palliative Care among Patients with Advanced Cancer and Their Caregivers on Early Palliative Care. Cancers. 2023; 15: 3656.","DOI":"10.3390\/cancers15143656"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Lu-Song J, Bakal JA, Younus S, Moran-Mendoza O, Harle I, Morales M, et al. The Impact of Integrated Palliative Care on Survival in Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Comparison. The American Journal of Hospice & Palliative Care. 2024; 41: 610\u2013618.","DOI":"10.1177\/10499091231194722"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018; 391: 1391\u20131454.","DOI":"10.1016\/S0140-6736(17)32513-8"},{"key":"ref79","unstructured":"Hospice UK. Hospice Accounts - Analysis of the accounts of UK charitable hospices for the year ended 31 March 2023. 2023. Available at: https:\/\/hospiceuk-files-prod.s3.eu-west-2.amazonaws.com\/s3fs-public\/2024-12\/J2095%20huk-Hospice-Accounts-2024-07.pdf (Accessed: 30 September 2025)."},{"key":"ref80","unstructured":"Richards M, Finlay I, Maskell R, Abrahams C, Brown M, Campbell S, et al. Palliative and End-of-Life Care. 2025. Available at: https:\/\/img1.wsimg.com\/blobby\/go\/e5bbd9ef-01fd-45c0-b4f4-1cf6b62157b9\/VOLUME%201%20REPORT%20FINAL%20170625.pdf (Accessed: 30 September 2025)."},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Crowley F, Smith CB, Arnold RM, Afezolli D. American Society of Clinical Oncology guideline update on palliative care for patients with cancer: Addressing the reality gap. Cancer. 2025; 131: e35656.","DOI":"10.1002\/cncr.35656"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Hui D, De La Rosa A, Chen J, Dibaj S, Delgado Guay M, Heung Y, et al. State of palliative care services at US cancer centers: An updated national survey. Cancer. 2020; 126: 2013\u20132023.","DOI":"10.1002\/cncr.32738"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Bradshaw A, Richards N, Hussain JA, Davies JM. We need to talk about social class: Why theories of social class matter for understanding inequities in palliative and end-of-life care. Palliative Medicine. 2024; 38: 1076\u20131078.","DOI":"10.1177\/02692163241296478"},{"key":"ref84","unstructured":"Health Services Safety Investigations Body. Investigation report: Variations in the delivery of palliative care services to adults. 2023. Available at: https:\/\/www.hssib.org.uk\/patient-safety-investigations\/variations-in-the-delivery-of-palliative-care-services-to-adults-in-england\/investigation-report\/ (Accessed: 30 September 2025)."},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Connor SR, Centeno C, Garralda E, Clelland D, Clark D. Estimating the Number of Patients Receiving Specialized Palliative Care Globally in 2017. Journal of Pain and Symptom Management. 2021; 61: 812\u2013816.","DOI":"10.1016\/j.jpainsymman.2020.09.036"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Rodin R, Swami N, Pope A, Hui D, Hannon B, Le LW, et al. Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster-randomized controlled trial in patients with advanced cancer. Cancer Medicine. 2022; 11: 1869\u20131878.","DOI":"10.1002\/cam4.4565"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Hui D, Titus A, Curtis T, Ho-Nguyen VT, Frederickson D, Wray C, et al. Implementation of the Edmonton Symptom Assessment System for Symptom Distress Screening at a Community Cancer Center: A Pilot Program. The Oncologist. 2017; 22: 995\u20131001.","DOI":"10.1634\/theoncologist.2016-0500"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Groenvold M, Petersen MA, Damkier A, Neergaard MA, Nielsen JB, Pedersen L, et al. Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care Trial. Palliative Medicine. 2017; 31: 814\u2013824.","DOI":"10.1177\/0269216317705100"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Iqbal J, Sutradhar R, Zhao H, Howell D, O\u2019Brien MA, Seow H, et al. Operationalizing Outpatient Palliative Care Referral Criteria in Lung Cancer Patients: A Population-Based Cohort Study Using Health Administrative Data. Journal of Palliative Medicine. 2020; 23: 670\u2013677.","DOI":"10.1089\/jpm.2019.0515"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Paiva CE, Paiva BSR, Menezes D, Zanini LE, Ciorlia JB, Miwa MU, et al. Development of a screening tool to improve the referral of patients with breast and gynecological cancer to outpatient palliative care. Gynecologic Oncology. 2020; 158: 153\u2013157.","DOI":"10.1016\/j.ygyno.2020.04.701"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Temel JS, Jackson VA, El-Jawahri A, Rinaldi SP, Petrillo LA, Kumar P, et al. Stepped Palliative Care for Patients With Advanced Lung Cancer: A Randomized Clinical Trial. JAMA. 2024; 332: 471\u2013481.","DOI":"10.1001\/jama.2024.10398"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Greer JA, Temel JS, El-Jawahri A, Rinaldi S, Kamdar M, Park ER, et al. Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial. JAMA. 2024; 332: 1153\u20131164.","DOI":"10.1001\/jama.2024.13964"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"He JC, Moffat GT, Podolsky S, Khan F, Liu N, Taback N, et al. Machine Learning to Allocate Palliative Care Consultations During Cancer Treatment. Journal of Clinical Oncology. 2024; 42: 1625\u20131634.","DOI":"10.1200\/JCO.23.01291"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Enguidanos S, Cardenas V, Wenceslao M, Hoe D, Mejia K, Lomeli S, et al. Health Care Provider Barriers to Patient Referral to Palliative Care. The American Journal of Hospice & Palliative Care. 2021; 38: 1112\u20131119.","DOI":"10.1177\/1049909120973200"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Dans M, Kutner JS, Agarwal R, Baker JN, Bauman JR, Beck AC, et al. NCCN Guidelines\u00ae Insights: Palliative Care, Version 2.2021. Journal of the National Comprehensive Cancer Network. 2021; 19: 780\u2013788.","DOI":"10.6004\/jnccn.2021.0033"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Marino D, Baratelli C, Guida G, Turco CGC, Lacidogna G, Sperti E, et al. Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. Recenti Progressi in Medicina. 2020; 111: 740\u2013748.","DOI":"10.1701\/3509.34965"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Bergenholtz H, Kragh C, Ziebell M, H\u00f8lge-Hazelton B, Gaardboe O. A joint hospital initiative to strengthen general palliative care in the hospital: an action research study on challenges and facilitators. BMC Palliative Care. 2025; 24: 121.","DOI":"10.1186\/s12904-025-01764-9"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Pitzer S, Kutschar P, Paal P, M\u00fclleder P, Lorenzl S, Wosko P, et al. Barriers for Adult Patients to Access Palliative Care in Hospitals: A Mixed Methods Systematic Review. Journal of Pain and Symptom Management. 2024; 67: e16\u2013e33.","DOI":"10.1016\/j.jpainsymman.2023.09.012"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Zimmermann C, Pope A, Hannon B, Bedard PL, Rodin G, Dhani N, et al. Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study. Supportive Care in Cancer. 2023; 31: 404.","DOI":"10.1007\/s00520-023-07870-9"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Moss CL, Malpass J, Fox L, Guerrero-Urbano T, Aggarwal A, Van Hemelrijck M. Implementing patient reported outcomes in cancer care: Lessons and strategies from a large UK Cancer Centre. Journal of Cancer Policy. 2025; 45: 100618.","DOI":"10.1016\/j.jcpo.2025.100618"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Glenwright BG, Simmich J, Cottrell M, O\u2019Leary SP, Sullivan C, Pole JD, et al. Facilitators and barriers to implementing electronic patient-reported outcome and experience measures in a health care setting: a systematic review. Journal of Patient-Reported Outcomes. 2023; 7: 13.","DOI":"10.1186\/s41687-023-00554-2"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Clark D, Baur N, Clelland D, Garralda E, L\u00f3pez-Fidalgo J, Connor S, et al. Mapping Levels of Palliative Care Development in 198 Countries: The Situation in 2017. Journal of Pain and Symptom Management. 2020; 59: 794\u2013807.e4.","DOI":"10.1016\/j.jpainsymman.2019.11.009"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Wang GH, Nesbit C, Rankin S. Voices of home-based palliative care community health workers in rural Malawi: a mixed methods study on factors affecting role and sustainability. Progress in Palliative Care. 2020; 28: 346\u2013353.","DOI":"10.1080\/09699260.2020.1760533"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Chalkidou A, Macmillan T, Grzeda MT, Peacock J, Summers J, Eddy S, et al. Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study. The Lancet. Oncology. 2021; 22: 98\u2013106.","DOI":"10.1016\/S1470-2045(20)30537-4"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, et al. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer. The New England Journal of Medicine. 2019; 380: 1235\u20131246.","DOI":"10.1056\/NEJMoa1815671"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Kelly R, Miller A, Roberts-Thomson R, Haydon A. Curative or non-curative: immunotherapy for advanced melanoma. JNCI Cancer Spectrum. 2025; 9: pkaf041.","DOI":"10.1093\/jncics\/pkaf041"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Lim AR, Rim CH. Oligometastasis: Expansion of Curative Treatments in the Field of Oncology. Medicina. 2023; 59: 1934.","DOI":"10.3390\/medicina59111934"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/6\/10.31083\/BJHM55141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:56:33Z","timestamp":1783421793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/6\/10.31083\/BJHM55141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":107,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1750-8460(26)03135-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm55141","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"article-number":"55141"}}